Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies
Not available.
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11925 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832577648869507072 |
|---|---|
| author | Qian Yan Jinlin Liu |
| author_facet | Qian Yan Jinlin Liu |
| author_sort | Qian Yan |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-0c4aae14b406438ba92d92f795d99010 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-0c4aae14b406438ba92d92f795d990102025-01-30T19:44:20ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.287052Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des MyélodysplasiesQian Yan0Jinlin Liu1Department of Clinical Laboratory, Wenling Hospital of Traditional Chinese Wenling, Zhejiang ProvinceDepartment of Clinical Laboratory, South China Hospital, Medical School, Shenzhen University, Shenzhen, 518111 Not available. https://haematologica.org/article/view/11925 |
| spellingShingle | Qian Yan Jinlin Liu Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies Haematologica |
| title | Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies |
| title_full | Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies |
| title_fullStr | Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies |
| title_full_unstemmed | Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies |
| title_short | Comment on: FLT3 ligand kinetic profile predicts response to treatment in patients with high-risk myelodysplastic syndrome / chronic myelomonocytic leukemia receiving CPX-351: a study from the Groupe Francophone des Myélodysplasies |
| title_sort | comment on flt3 ligand kinetic profile predicts response to treatment in patients with high risk myelodysplastic syndrome chronic myelomonocytic leukemia receiving cpx 351 a study from the groupe francophone des myelodysplasies |
| url | https://haematologica.org/article/view/11925 |
| work_keys_str_mv | AT qianyan commentonflt3ligandkineticprofilepredictsresponsetotreatmentinpatientswithhighriskmyelodysplasticsyndromechronicmyelomonocyticleukemiareceivingcpx351astudyfromthegroupefrancophonedesmyelodysplasies AT jinlinliu commentonflt3ligandkineticprofilepredictsresponsetotreatmentinpatientswithhighriskmyelodysplasticsyndromechronicmyelomonocyticleukemiareceivingcpx351astudyfromthegroupefrancophonedesmyelodysplasies |